NEW YORK (GenomeWeb News) – The National Institutes of Health's Clinical and Translational Science Awards program is "contributing significantly" to the development of advancement of new clinical and translational research in the US, but some organizational changes, refocusing, and accountability could improve the program, according to the Institute of Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.